NCT02936401 is a NA clinical trial of MBSR in Impaired Cognition, sponsored by University of California, San Francisco.

Who is sponsoring NCT02936401?

NCT02936401 is sponsored by University of California, San Francisco.

What drugs are being tested in NCT02936401?

Interventions in NCT02936401: MBSR.

What condition does NCT02936401 study?

NCT02936401 studies Impaired Cognition, HIV Infection.

Is NCT02936401 still recruiting?

NCT02936401 is currently completed. Last updated 7 August 2020.

Last reviewed 2020-08-07 · How we verify

NCT02936401

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mindfulness Based Stress Reduction for Older Adults With HIV Associated Neurocognitive Disorders

Completed NA Last updated 7 August 2020

What this trial tests

NA trial testing MBSR in Impaired Cognition in 180 participants. Completed in 7 November 2019.

Timeline

30 March 2015

Primary endpoint
7 November 2019

7 November 2019

Quick facts

Lead sponsor	University of California, San Francisco
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	180
Start date	30 March 2015
Primary completion	7 November 2019
Estimated completion	7 November 2019
Sites	1 location across United States

Drugs / interventions tested

MBSR

Conditions studied

Impaired Cognition — all drugs for Impaired Cognition →
HIV Infection — all drugs for HIV Infection →

Sponsor

University of California, San Francisco

Who can join

55 and older, any sex, with Impaired Cognition or HIV Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the efficacy of Mindfulness Based Stress Reduction (MBSR) to alleviate stress, anxiety, and depressive symptoms, and improve attention among patients aged 60 or older who suffer from HIV-associated neurocognitive disorders (HAND) and have maximized treatment options.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

CNS Neurotoxicity of Antiretrovirals.
Lanman T, Letendre S, Ma Q, Bang A, et al · · 2021 · cited 81× · PMID 31823251 · DOI 10.1007/s11481-019-09886-7
Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management.
Ellis RJ, Marquine MJ, Kaul M, Fields JA, et al · · 2023 · cited 66× · PMID 37816937 · DOI 10.1038/s41582-023-00879-y
Mindfulness-Based Interventions for Adults Living with HIV/AIDS: A Systematic Review and Meta-analysis.
Scott-Sheldon LAJ, Balletto BL, Donahue ML, Feulner MM, et al · · 2019 · cited 49× · PMID 30054765 · DOI 10.1007/s10461-018-2236-9
Mindfulness-based stress reduction for HIV-associated neurocognitive disorder: Rationale and protocol for a randomized controlled trial in older adults.
Addington EL, Javandel S, De Gruttola V, Paul R, et al · · 2020 · cited 5× · PMID 32942053 · DOI 10.1016/j.cct.2020.106150

Verify or expand the search:

Other trials of MBSR

Trials testing the same drug.

NCT07307196 — The Effect of a Mindfulness-Based Stress Reduction Program on Pregnancy Adaptation, Stress, and Fetal Anxiety Levels in · NA · not yet recruiting
NCT06628986 — MBSR and NLP, Postpartum Breastfeeding and Depression · NA · recruiting
NCT06022887 — Time-Restricted Eating and Mindfulness-Based Stress Reduction to Reduce the Risk of Early-Onset Colorectal Cancer · NA · completed
NCT05615337 — Mindfulness Training: the Effects of a Stress Reduction Program on Older Portuguese-speaking People in Luxembourg · NA · completed
NCT06991309 — Mindfulness-based Stress Reduction Effects on Depression, Anxiety and Internalized Stigma Compared With Treatment-As-Usu · NA · completed

Other recruiting trials for Impaired Cognition

Currently open trials in the same condition.

NCT04556227 — Simultaneous Recumbent Cycling and Cognitive Training · NA · recruiting

Other University of California, San Francisco trials

Trials by the same sponsor.

NCT05284773 — Screening for Acute Malnutrition · NA · withdrawn
NCT04634851 — Video Home Visits for Dietary Counselling · NA · not yet recruiting
NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M · Phase 1, PHASE2 · not yet recruiting
NCT07534098 — Intervention for Hearing Health Among Native Americans · NA · not yet recruiting
NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02936401 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
Last refreshed: 7 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02936401.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing